Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62,205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
T Cell Defects: New Insights Into the Primary Resistance Factor to CD19/CD22 Cocktail CAR T-Cell Immunotherapy in Diffuse Large B-Cell Lymphoma.
Wang J, Shen K, Mu W, Li W, Zhang M, Zhang W, Li Z, Ge T, Zhu Z, Zhang S, Chen C, Xing S, Zhu L, Chen L, Wang N, Huang L, Li D, Xiao M, Zhou J. Wang J, et al. Among authors: zhang m, zhang s, zhang w. Front Immunol. 2022 Apr 27;13:873789. doi: 10.3389/fimmu.2022.873789. eCollection 2022. Front Immunol. 2022. PMID: 35572515 Free PMC article.
Clinical Utility of Droplet Digital PCR to Monitor BCR-ABL1 Transcripts of Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Post-chimeric Antigen Receptor19/22 T-Cell Cocktail Therapy.
Guan Y, Zhang M, Zhang W, Wang J, Shen K, Zhang K, Yang L, Huang L, Wang N, Xiao M, Zhou J. Guan Y, et al. Among authors: zhang m, zhang w, zhang k. Front Oncol. 2021 Apr 7;11:646499. doi: 10.3389/fonc.2021.646499. eCollection 2021. Front Oncol. 2021. PMID: 33898316 Free PMC article.
MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy.
Wang J, Shang Z, Wang J, Xu J, Li W, Guan Y, Yang L, Zhang W, Shen K, Zhang M, Wang J, Chen L, Li Q, He C, Wang N, Huang L, Xiao Y, Xiao M, Zhou J. Wang J, et al. Among authors: zhang m, zhang w. J Immunother Cancer. 2021 Jun;9(6):e002029. doi: 10.1136/jitc-2020-002029. J Immunother Cancer. 2021. PMID: 34078654 Free PMC article. No abstract available.
[Treatment of relapsed and refractory EZB/C3 subtype DLBCL with chidamide in combination of R2-CHOP: a case report].
Yang L, Zhang W, Zhang ML, Shen KF, Wang JC, Guan YQ, Cai HD, Bao YH, Xiao M, Zhou JF, Zheng M. Yang L, et al. Among authors: zhang w, zhang ml. Zhonghua Xue Ye Xue Za Zhi. 2021 May 14;42(5):436-437. doi: 10.3760/cma.j.issn.0253-2727.2021.05.016. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 34218590 Free PMC article. Chinese. No abstract available.
62,205 results
You have reached the last available page of results. Please see the User Guide for more information.